GlassScriptPhysician profile
Bhuvana Sagar
NPI 1568527927
$12,917.83
in general payments reported to CMS, 2019-2025
76 companies · $5,220 in 2025
The $5,220 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2021: $190 · 2022: $938 · 2023: $1,649 · 2024: $4,755 · 2025: $5,220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $744.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,880.19 |
| Education | $743.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $825.09 | 2022-2025 | Pomalyst, Reblozyl, Opdualag |
| E.R. Squibb & Sons, L.L.C. | $812.40 | 2019-2025 | Opdivo, Opdualag |
| Merck Sharp & Dohme LLC | $804.55 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Janssen Biotech, INC. | $763.46 | 2022-2025 | Rybrevant, Talvey, Tecvayli |
| Astrazeneca Pharmaceuticals LP | $646.14 | 2022-2025 | Enhertu, Imfinzi, Calquence |
| Tempus Ai, INC | $547.77 | 2024-2025 | Xt Cdx |
| Pfizer INC. | $539.09 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $461.49 | 2021-2025 | |
| Eisai INC. | $429.42 | 2023-2025 | |
| Glaxosmithkline, LLC. | $418.36 | 2022-2025 | Ojjaara, Blenrep, Jemperli |
| Astellas Pharma US INC | $355.08 | 2024-2025 | Vyloy, Padcev, Xtandi |
| Daiichi Sankyo INC. | $324.63 | 2022-2025 | Enhertu, Datroway |
| Jazz Pharmaceuticals INC. | $310.20 | 2022-2025 | |
| Sobi, INC | $278.60 | 2023-2025 | |
| Abbvie INC. | $278.38 | 2023-2025 | Venclexta |
Show all 76 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $251.69 | 2022-2025 | |
| Springworks Therapeutics, INC. | $239.62 | 2024-2025 | Ogsiveo, Gomekli |
| Rigel Pharmaceuticals, INC. | $219.44 | 2021-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Beigene USA, INC. | $211.73 | 2023-2025 | Brukinsa |
| Aveo Pharmaceuticals, INC. | $198.37 | 2022-2025 | Fotivda |
| Genentech USA, INC. | $189.05 | 2021-2025 | Lunsumio, Tecentriq, Polivy |
| Gilead Sciences, INC. | $182.50 | 2021-2025 | Trodelvy |
| Puma Biotechnology, INC. | $164.78 | 2024-2025 | |
| Kerecis Limited | $163.63 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Array Biopharma INC | $153.93 | 2024-2025 | Braftovi, Mektovi, Tukysa |
| Pharmacosmos Therapeutics INC. | $152.60 | 2023-2025 | Monoferric |
| Incyte Corporation | $147.18 | 2023-2025 | Jakafi, Zynyz, Monjuvi |
| Boston Scientific Corporation | $141.17 | 2024 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Karyopharm Therapeutics INC. | $138.80 | 2022-2025 | Xpovio |
| Taiho Oncology, INC. | $135.37 | 2024-2025 | |
| Tersera Therapeutics LLC | $129.85 | 2024-2025 | Zoladex, Xermelo |
| Lilly USA, LLC | $118.33 | 2024-2025 | Verzenio, Jaypirca, Retevmo |
| Bayer Healthcare Pharmaceuticals INC. | $114.80 | 2022-2025 | |
| Recordati_rare_diseases_inc. | $113.70 | 2024-2025 | Enjaymo, Sylvant |
| Takeda Pharmaceuticals U.S.A., INC. | $109.49 | 2024-2025 | Ninlaro, Iclusig, Fruzaqla |
| Deciphera Pharmaceuticals INC. | $108.83 | 2024-2025 | Qinlock, Romvimza, Tgct |
| Kite Pharma, INC. | $98.92 | 2025 | Yescarta |
| Pharmaessentia USA Corporation | $96.95 | 2023-2025 | Besremi |
| Sanofi-Aventis U.S. LLC | $92.99 | 2025 | |
| Stemline Therapeutics INC. | $86.04 | 2023 | Orserdu |
| Intuitive Surgical, INC. | $76.92 | 2025 | |
| Beone Medicines USA, INC. | $72.61 | 2025 | Brukinsa |
| Kyowa Kirin, INC. | $69.93 | 2025 | |
| Alexion Pharmaceuticals, INC. | $68.44 | 2023-2024 | Ultomiris |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.36 | 2022-2024 | Gilotrif |
| Servier Pharmaceuticals LLC | $61.43 | 2022-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $59.58 | 2023 | Imbruvica |
| Mirati Therapeutics, INC. | $57.63 | 2024 | Krazati |
| Ipsen Biopharmaceuticals, INC | $57.51 | 2024 | Onivyde, Somatuline Depot |
| Cti Biopharma Corp. | $50.93 | 2023 | Vonjo |
| Amgen INC. | $47.99 | 2022 | |
| Spectrum Pharmaceuticals INC. | $43.07 | 2024-2025 | Rolvedon |
| Regeneron Healthcare Solutions, INC. | $41.13 | 2024 | Libtayo |
| Myriad Genetic Laboratories, INC. | $40.89 | 2023-2024 | Myrisk |
| Exelixis INC. | $40.10 | 2024-2025 | Cabometyx |
| Iovance Biotherapeutics, INC. | $38.03 | 2025 | Amtagvi |
| Medtronic, INC. | $36.41 | 2022 | |
| Dendreon Pharmaceuticals LLC | $32.52 | 2024 | Provenge |
| Morphosys, US INC. | $32.41 | 2021-2023 | Monjuvi |
| Sanofi US Services INC. | $31.31 | 2024 | |
| Emd Serono, INC. | $30.57 | 2024 | |
| Sumitomo Pharma America, INC. | $29.77 | 2023 | Orgovyx |
| Geron Corporation | $28.63 | 2025 | Rytelo |
| Janssen Pharmaceuticals, INC | $28.57 | 2024 | Darzalex, Tecvayli, Talvey |
| Myovant Sciences INC. | $25.49 | 2021 | |
| Blueprint Medicines Corporation | $24.75 | 2023 | Ayvakit |
| Caris Mpi, INC. | $22.81 | 2025 | Mi Cancer Seek |
| Alnylam Pharmaceuticals INC. | $21.32 | 2025 | Givlaari |
| Sirtex Medical INC | $18.94 | 2023 | Sir-Spheres Microspheres |
| Menarini Silicon Biosystems, INC. | $18.04 | 2024 | |
| Seagen INC. | $17.78 | 2023 | Padcev |
| Agios Pharmaceuticals, INC. | $16.56 | 2025 | Pyrukynd |
| Pharmaand Gmbh | $15.97 | 2025 | Rubraca |
| Tolmar, INC. | $15.97 | 2025 | Eligard, Rubraca |
| Shield Therapeutics INC | $13.78 | 2025 | |
| Adaptive Biotechnologies Corporation | $13.26 | 2023 | Clonoseq |
Drugs and devices associated with these payments
Kerecis Omega3 Marigen $655Keytruda $652Enhertu $550Lenvima $429Rybrevant $381Opdivo $374Xt Cdx $367Brukinsa $284Pomalyst $275Opdualag $272Tukysa $269Lynparza $241Ojjaara $238Zepzelca $230Ogsiveo $208Talvey $204Tecvayli $204Tavalisse $199Rezlidhia $199Vonjo $198Sarclisa $197Enjaymo $196Imbruvica $191Fotivda $181Reblozyl $176Xtandi $172Ibrance $169Darzalex $168Kerecis Omega3 Surgiclose $164Pluvicto $159Braftovi $157Monoferric $153Talzenna $144Therasphere Y90 Glass Microspheres 10 Gbq $141Imfinzi $141Lonsurf $135Inqovi $135Epkinly $131Mektovi $127Jaypirca $118Verzenio $118Xpovio $118Scemblix $116Qinlock $109Inlyta $103Jakafi $102Kisqali $101Padcev $101Welireg $100Adcetris $99.88Elrexfio $99.88Yescarta $98.92Besremi $96.95Zoladex $95.28Vyloy $94.05Doptelet $93.83Venclexta $92.87Orserdu $86.04Gavreto $81.38Trodelvy $77.41Da Vinci Surgical System $76.92Nerlynx $72.89Nubeqa $71.11Orgovyx $70.81Poteligeo $69.93Ultomiris $68.44Akeega $65.14Erleada $65.14Lunsumio $60.66Bosulif $60.12Ayvakit $58.28Krazati $57.63Onivyde $57.51Lorbrena $56.76Xofigo $49.04Retevmo $47.55Tecentriq $46.07Fabhalta $43.39Rolvedon $43.07Tibsovo $42.92Libtayo $41.13Myrisk $40.89Cabometyx $40.10Synagis $38.07Polivy $38.05Amtagvi $38.03Calquence $34.95Xermelo $34.57Gilotrif $33.79Monjuvi $33.42Romvimza $32.59Provenge $32.52Abecma $32.46Lupron Depot $32.17Rubraca $31.94Gomekli $31.88Iclusig $30.88Ninlaro $30.88Rytelo $28.63Itovebi $28.55
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bhuvana Sagar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.